FinCanna (CSE:CALI) has been featured in an article published by CannabisFN (CFN) Media Group regarding the company’s flagship investment in Cultivation Technologies Inc (CTI) and how it’s uniquely position in generating near term revenue. The article describes FinCanna as a “royalty company that’s focused on building a portfolio of investments in scalable, best-in-class projects in the licensed medical cannabis sector.”
The article talked about the recently launched interim medical cannabis extraction facility in advance to the permanent one in Coachella, California. The article further addressed the new regulations placed in California which increases CTI’s production capacity from 20 percent to 100 percent.
“As revenues from the extraction and manufacturing business are now expected to be the largest segment of CTI’s Coachella Campus, the increase in expected royalties to FinCanna are very significant. We continue to be impressed by CTI’s exceptional management team and support their strategic approach to the market,” said Fincanna CEO Andriyako Herchak.
Lastly, the article discussed the company’s long term ambitions to fund a variety of licensed medical cannabis operations in exchange for an ongoing royalty over time and looking ahead how is the company a unique investment opportunity for investors.
To read the full article, click here.
Click here to connect with FinCanna (CSE:CALI) for an Investor Presentation
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).